Barbara Nelsen Moderates A Biomanufacturing Webinar

In addition to publishing journal articles, the publication Cell and Gene Therapy Insights also hosts monthly webinars with leading experts to discuss some of the critical issues the industry is facing when it comes to the successful commercialization of cell and gene therapies.

In October/November this year, the topic is factors that influence decision-making in manufacturing cell and gene therapies. This discussion will be moderated by Barbara Nelsen, President and CEO of Nelsen Biomedical featuring a panel of experts to represent key stakeholder groups, including Big Pharma, early stage companies, manufacturing organizations and the investor community. Those speaking include Brian Polzak, Managing Director at Aquilo Partners and Kim Warren, Head of Operations at AvroBio.